Adjuvant drug therapy for decompression sickness: a review.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003374:Coumarins / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use; D003665:Decompression Sickness / Q000188:drug therapy* / Q000628:therapy; D003911:Dextrans / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005440:Fluid Therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000889:Anti-Arrhythmia Agents; D001993:Bronchodilator Agents; D003374:Coumarins; D003911:Dextrans; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D009525:Niacin; D003533:Cyproheptadine; D007980:Levodopa; D004176:Dipyridamole; D006493:Heparin; D003975:Diazepam; D001241:Aspirin; D007213:Indomethacin